284 related articles for article (PubMed ID: 7750046)
1. Hemostasis and atherosclerosis.
Warkentin TE
Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046
[TBL] [Abstract][Full Text] [Related]
2. Role of the von Willebrand factor in atherogenesis.
Green D
Artery; 1979 Mar; 5(3):262-72. PubMed ID: 316693
[TBL] [Abstract][Full Text] [Related]
3. [Role of the hemostatic system in pathogenesis of atherosclerosis as the main etiology of coronary ischemia] [corrected].
Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
Pol Merkur Lekarski; 2004 May; 16(95):465-7. PubMed ID: 15518428
[TBL] [Abstract][Full Text] [Related]
4. Haemostatic risk factors for cardiovascular diseases.
Koenig W
Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
[TBL] [Abstract][Full Text] [Related]
5. [Significance of the coagulation and fibrinolytic parameters as predictors for carotid atherosclerosis].
Nomura E; Kohriyama T; Yamaguchi S; Kajikawa H; Nakamura S
Rinsho Shinkeigaku; 1996 Jun; 36(6):741-5. PubMed ID: 8937194
[TBL] [Abstract][Full Text] [Related]
6. Assessment of hemostatic risk factors in predicting arterial thrombotic events.
Feinbloom D; Bauer KA
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2043-53. PubMed ID: 16100033
[TBL] [Abstract][Full Text] [Related]
7. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
8. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic risk factors for atherothrombotic disease: an epidemiologic view.
Folsom AR
Thromb Haemost; 2001 Jul; 86(1):366-73. PubMed ID: 11487026
[TBL] [Abstract][Full Text] [Related]
10. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
Jaeger BR; Labarrere CA
Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.
Smith EB
Clin Haematol; 1986 May; 15(2):355-70. PubMed ID: 3524931
[TBL] [Abstract][Full Text] [Related]
12. [The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis].
Drouet L; Mazoyer E; Bal dit Sollier C; Hainaud P; Ripoll L
Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():41-51. PubMed ID: 9833079
[TBL] [Abstract][Full Text] [Related]
13. [Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms].
Lenzi S; Scanu A; De Caterina R
G Ital Cardiol; 1996 Oct; 26(10):1203-25. PubMed ID: 9005165
[TBL] [Abstract][Full Text] [Related]
14. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
15. Altered blood coagulation in patients with posttraumatic stress disorder.
von Känel R; Hepp U; Buddeberg C; Keel M; Mica L; Aschbacher K; Schnyder U
Psychosom Med; 2006; 68(4):598-604. PubMed ID: 16868270
[TBL] [Abstract][Full Text] [Related]
16. Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease.
Mari D; Parnetti L; Coppola R; Bottasso B; Reboldi GP; Senin U; Mannucci PM
Thromb Haemost; 1996 Feb; 75(2):216-8. PubMed ID: 8815562
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
[TBL] [Abstract][Full Text] [Related]
18. The investigation of a heart valve patient with suspected hypercoagulability.
Gough SC; Prentice CR
J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
20. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
